© 2018 by ROS Therapeutics

A New targeted MTX underway for RA

2018-11-11

Health Europa Quarterly (issue 07) highlights the advantages and disadvantages of the currently recommended first-line treatment for rheumatoid arthritis and reflects on recent research into a possible alternative: A new targeted-MTX treatment underway for rheumatoid arthritis

Copenhagen, Denmark, November 11th, 2018

Read the full article here